FDA approves first treatment for rare form of skin cancer
The FDA granted accelerated approval to Bavencio (avelumab) for treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma, including those who have not received prior chemotherapy. This is the first FDA-approved treatment for metastatic MCC. March 23, 2017